Approval · Notice of Compliance 12431 · 2011
BONAMINE: Notice of Compliance 12431
Issued June 15, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12431
- Date
- June 15, 2011
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antiemetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BONAMINE | 02368838 | Cancelled Pre Market |
Medicinal ingredients
- MECLIZINE HYDROCHLORIDE 25 MG per TAB